Literature DB >> 20861724

Short-term corneal response to cross-linking in rabbit eyes assessed by in vivo confocal laser scanning microscopy and histology.

Marine Hovakimyan1, Rudolf Guthoff, Steffi Knappe, Andrey Zhivov, Andreas Wree, Alexander Krüger, Alexander Heisterkamp, Oliver Stachs.   

Abstract

PURPOSE: Corneal cross-linking for the treatment of keratoconus has been tested in animal trials and proven clinically. A combination of in vivo confocal laser scanning microscopy (CLSM) and histology was used in rabbit corneas to assess early modifications at the cellular level after corneal cross-linking.
METHODS: Twelve New Zealand male rabbits were tested; in each case, the right eye was the study eye and left eye was the control eye. In vivo CLSM was performed on both eyes before and at 3 days and 1 week after cross-linking. Keratocyte and endothelial cell densities were determined by CLSM before and after cross-linking. After CLSM, the corneas were excised and processed for histology and immunohistochemistry.
RESULTS: Massive edema was observed 3 days after cross-linking. The corneal epithelium had already closed again by day 3. No cellular structures were detected in the stroma and endothelium. One week after cross-linking, normal corneal transparency and thickness were restored. The anterior stroma still lacked nuclei. The number of nuclei in the posterior stroma was significantly lower than that in the intact corneas. Highly reflective spindle-shaped structures were detected in the posterior stroma. The endothelial monolayer had closed again but still showed significantly decreased cell density. At 1 week after cross-linking, immunohistochemical staining revealed the presence of proliferating cells in the corneal epithelium, posterior stroma, and endothelium.
CONCLUSIONS: The early response of the rabbit cornea to cross-linking was successfully characterized at the cellular level by in vivo CLSM and histology, and the results obtained with both techniques correlated positively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20861724     DOI: 10.1097/ICO.0b013e3181e16d93

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Spatial characterization of corneal biomechanical properties with optical coherence elastography after UV cross-linking.

Authors:  Michael D Twa; Jiasong Li; Srilatha Vantipalli; Manmohan Singh; Salavat Aglyamov; Stanislav Emelianov; Kirill V Larin
Journal:  Biomed Opt Express       Date:  2014-04-04       Impact factor: 3.732

2.  Deep anterior lamellar keratoplasty in eyes previously treated with collagen crosslinking for keratoconus: 3-year results.

Authors:  Anıl Kubaloglu; Esin Sogutlu Sari; Arif Koytak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-08       Impact factor: 3.117

3.  Assessment of corneal thickness and keratocyte density in a rabbit model of laser in situ keratomileusis using scanning laser confocal microscopy.

Authors:  Michael D Twa; Michael J Giese
Journal:  Am J Ophthalmol       Date:  2011-08-25       Impact factor: 5.258

4.  Collagen cross-linking: current status and future directions.

Authors:  Marine Hovakimyan; Rudolf F Guthoff; Oliver Stachs
Journal:  J Ophthalmol       Date:  2012-01-12       Impact factor: 1.909

5.  High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea.

Authors:  Yirui Zhu; Peter S Reinach; Hanlei Zhu; Qiufan Tan; Qinxiang Zheng; Jia Qu; Wei Chen
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

6.  Cornea Collagen Cross-linking for Keratoconus: A Comparison between Accelerated and Conventional Methods.

Authors:  Hasan Razmjoo; Alireza Peyman; Ali Rahimi; Hoda Jafari Modrek
Journal:  Adv Biomed Res       Date:  2017-02-22

7.  Topical Corneal Cross-Linking Solution Delivered Via Corneal Reservoir in Dutch-Belted Rabbits.

Authors:  Mariya Zyablitskaya; Charles Jayyosi; Anna Takaoka; Kristin M Myers; Leejee H Suh; Takayuki Nagasaki; Stephen L Trokel; David C Paik
Journal:  Transl Vis Sci Technol       Date:  2020-08-11       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.